Lv11
80 积分 2025-05-25 加入
Osimertinib and Stereotactic Radiosurgery for Brain Metastases in EGFR-Mutated Lung Cancer: The STARLET Joint Analysis of OUTRUN and LUOSICNS Randomized Trials
9小时前
待确认
Izalontamab brengitecan, an EGFR and HER3 bispecific antibody–drug conjugate, versus chemotherapy in heavily pretreated recurrent or metastatic nasopharyngeal carcinoma: a multicentre, randomised, open-label, phase 3 study in China
1个月前
已完结
Histological transformation in lung cancer: a single-arm meta-analysis and systematic review
2个月前
已关闭
OA10.04 Phase II Study of Iza-Bren (BL-B01D1) Combo With Osimertinib in EGFR Mutated Locally Advanced or Metastatic NSCLC Patients
3个月前
已关闭
Head and Neck Cancer
4个月前
已完结
Sequential therapy of metastatic urothelial cancer with monomethyl auristatin E (MMAE)-containing antibody-drug conjugates for different targets
4个月前
已完结
Head and Neck Cancer Salvage Surgery in the Era of Immunotherapy and Beyond
4个月前
已完结
Garsorasib in patients with KRASG12C-mutated non-small-cell lung cancer in China: an open-label, multicentre, single-arm, phase 2 trial
4个月前
已完结
Lineage plasticity: a new dilemma in lung cancer treatment
5个月前
已完结
Small cell lung cancer transdifferentiation: not a negligible phenomenon
5个月前
已完结
皖公网安备34019202002308
